U.S. Physical Therapy, Inc. USPH
Set alert
85.83 USD +0.93 +1.10%
As of Nov 3, 2:55 PM ET
85.05 Day range 86.60
58.19 52-week range 90.94
- YTD
- +9.91%
- 1 year
- -1.27%
- Open
- 84.95
- Prev close
- 84.90
- Mkt cap
- 1.28B
- Vol
- 55.03K
- Avg vol
- 181.13K
- EPS
- 0.18
- P/E
- 476.83
- Div yield
- 2.13%
More statistics
- Low
- 85.05
- High
- 86.60
- Forward P/E
- 25.51
- Beta
- 1.13
- Short ratio
- 6.28
- Inst. own
- 112.62%
- Dividend
- 1.84
- Ex-div date
- Aug 20, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 82.82
- 200-d avg
- 76.75
- 1y target
- 97.83
Analyst view
Consensus: buy
Buy
Price target (mean) 97.83 +14.0% upside
Now 85.83
- Target (low)
- 95.00
- Target (mean)
- 97.83
- Target (high)
- 101.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
- Strong buy4
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.725 | 0.57 – 0.90 | 0.66 | +9.9% | 214.54M | +8.8% | 6 |
| Next quarter | 0.90833 | 0.80 – 1.10 | 0.67 | +35.6% | 220.97M | +9.0% | 6 |
| Current year | 2.89 | 2.70 – 3.18 | 2.63 | +9.8% | 847.89M | +8.6% | 5 |
| Next year | 3.33 | 2.98 – 3.80 | 2.89 | +15.3% | 912.26M | +7.6% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 11, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 10, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Jun 24, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| May 13, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| May 8, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Feb 20, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Jan 5, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Nov 24, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 24, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Aug 8, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Jul 1, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Apr 22, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Mar 19, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 28, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Dec 16, 2024 | B of A Securities | Upgrade | Neutral | Buy |
| Dec 16, 2024 | JMP Securities | Initiated | — | Market Outperform |
| Dec 3, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 21, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Nov 7, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 9, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 7, 2024 | B of A Securities | Downgrade | Buy | Neutral |
| Sep 20, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Aug 15, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| May 9, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Mar 13, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 1, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Jan 3, 2024 | Barrington Research | Maintained | Outperform | Outperform |
| Nov 17, 2023 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 9, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| Sep 22, 2023 | JP Morgan | Initiated | — | Overweight |
